Insider sale
TERNS PHARMACEUTICALS, INC.
$659.1K
100.91K shares
What this filing means
VIVO CAPITAL FUND VIII, L.P. plans to sell 100.91K shares of TERNS PHARMACEUTICALS, INC. valued at approximately $659.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/3/2024ACC: 0000048966-24-000010
10% Owner
Since Feb 2021
100.91K
Shares to sell
$659.1K
Approx. market value
39.42K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
IPO Allocation
Cash
2/4/2021
39.42KTotal acquired39.42K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/4/2021 | IPO Allocation Cash | 39.42K | — |
| Total | 39.42K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
22.08K
Market value
$146.8K
4/2/2024
—Completed
Units to sell
39.41K
Market value
$275.7K
4/1/2024
Planned — Approximate Date
NasdaqPlanned
Units to sell
39.42K
Market value
$236.5K
4/3/2024
Total
Units
100.91K
Value
$659.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/2/2024 | 22.08K | $146.8K | — | Completed |
4/1/2024 | 39.41K | $275.7K | — | Completed |
| Planned — Approximate Date | ||||
4/3/2024 | 39.42K | $236.5K | Nasdaq | Planned |
| Total | 100.91K | $659.1K | ||